PAVmed Inc. is a highly-differentiated multi-product medical device company.  The Company's product pipeline includes NextFlo, a disposable infusion pump; PortIO, a long-term implantable vascular access device; Caldus, a disposable tissue ablation device; CarpX, a percutaneous device to treat carpal tunnel syndrome; and NextCath, a self-anchoring short-term catheter. In addition to its lead projects, PAVmed is working on projects which are currently in the conceptual phase. These additional projects cover a wide range of clinical conditions and procedures, including sleep apnea, extracorporeal membrane oxygenation, laparoscopic hernia repair, cardiac surgery, interventional cardiology and endotracheal intubation.

Queens, US
Size (employees)
3 (est)+50%
PAVmed was founded in 2014 and is headquartered in Queens, US

PAVmed Office Locations

PAVmed has an office in Queens
Queens, US (HQ)
4600 251-1 Grand Central Parkway Service Road
Show all (1)

PAVmed Financials and Metrics

PAVmed Financials


Net income (Q3, 2017)

(5.1 m)

EBIT (Q3, 2017)

(2 m)

Market capitalization (31-Oct-2017)

58.8 m

Closing share price (31-Oct-2017)


Cash (30-Sep-2017)

3.1 m
PAVmed's current market capitalization is $58.8 m.
USDFY, 2016

R&D expense

607 k

General and administrative expense

1.1 m

Operating expense total

1.7 m

Net Income

(5.7 m)
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

R&D expense

656.7 k701.7 k704.9 k

General and administrative expense

1.5 m1.3 m1.3 m

Operating expense total

1.3 m1.9 m2.2 m2 m2 m

Depreciation and amortization

5.3 k
USDFY, 2016


585.7 k

Accounts Receivable

82.3 k


155.5 k

Current Assets

741.2 k
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


3 m1.8 m905.7 k82.1 k3.1 m


103.3 k

Current Assets

3.1 m2 m1.1 m206.7 k3.2 m

Total Assets

3.2 m2 m1.1 m226.5 k3.2 m
    USDFY, 2016

    Net Income

    (5.7 m)

    Depreciation and Amortization

    3.8 k


    (146.7 k)

    Accounts Payable

    877.6 k
    USDQ2, 2016Q3, 2016Q1, 2017

    Net Income

    (1.3 m)(1.9 m)(4.3 m)

    Accounts Payable

    216.1 k609.9 k934.2 k
      Y, 2017

      Financial Leverage

      -0.5 x
      Show all financial metrics

      PAVmed Market Value History

      PAVmed's Web-traffic and Trends

      PAVmed Online and Social Media Presence

      PAVmed Company Life and Culture

      You may also be interested in